Literature DB >> 7667099

The secondary structure and sequence optimization of an RNA ligase ribozyme.

E H Ekland1, D P Bartel.   

Abstract

In vitro selection can generate functional sequence variants of an RNA structural motif that are useful for comparative analysis. The technique is particularly valuable in cases where natural variation is unavailable or non-existent. We report the extension of this approach to a new extreme--the identification of a 112 nt ribozyme secondary structure imbedded within a 186 nt RNA. A pool of 10(14) variants of an RNA ligase ribozyme was generated using combinatorial chemical synthesis coupled with combinatorial enzymatic ligation such that 172 of the 186 relevant positions were partially mutagenized. Active variants of this pool were enriched using an in vitro selection scheme that retains the sequence variability at positions very close to the ligation junction. Ligases isolated after four rounds of selection catalyzed self-ligation up to 700 times faster than the starting sequence. Comparative analysis of the isolates indicated that when complexed with substrate RNAs the ligase forms a nested, double pseudo-knot secondary structure with seven stems and several important joining segments. Comparative analysis also suggested the identity of mutations that account for the increased activity of the selected ligase variants; designed constructs incorporating combinations of these changes were more active than any of the individual ligase isolates.

Mesh:

Substances:

Year:  1995        PMID: 7667099      PMCID: PMC307182          DOI: 10.1093/nar/23.16.3231

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  In vitro selection of RNAs that undergo autolytic cleavage with Pb2+.

Authors:  T Pan; O C Uhlenbeck
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

2.  Modelling of the three-dimensional architecture of group I catalytic introns based on comparative sequence analysis.

Authors:  F Michel; E Westhof
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

3.  In vitro genetic analysis of the Tetrahymena self-splicing intron.

Authors:  R Green; A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

4.  In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions.

Authors:  A Berzal-Herranz; S Joseph; J M Burke
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

5.  HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.

Authors:  D P Bartel; M L Zapp; M R Green; J W Szostak
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

6.  CUUCGG hairpins: extraordinarily stable RNA secondary structures associated with various biochemical processes.

Authors:  C Tuerk; P Gauss; C Thermes; D R Groebe; M Gayle; N Guild; G Stormo; Y d'Aubenton-Carafa; O C Uhlenbeck; I Tinoco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Structural conventions for group I introns.

Authors:  J M Burke; M Belfort; T R Cech; R W Davies; R J Schweyen; D A Shub; J W Szostak; H F Tabak
Journal:  Nucleic Acids Res       Date:  1987-09-25       Impact factor: 16.971

Review 8.  In vitro selection and evolution of RNA: applications for catalytic RNA, molecular recognition, and drug discovery.

Authors:  J M Burke; A Berzal-Herranz
Journal:  FASEB J       Date:  1993-01       Impact factor: 5.191

9.  U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts.

Authors:  D E Tsai; D S Harper; J D Keene
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

10.  RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.

Authors:  C Tuerk; S MacDougal; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more
  36 in total

1.  Design and optimization of effector-activated ribozyme ligases.

Authors:  M P Robertson; A D Ellington
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  A complex ligase ribozyme evolved in vitro from a group I ribozyme domain.

Authors:  L Jaeger; M C Wright; G F Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  A ribozyme selected from variants of U6 snRNA promotes 2',5'-branch formation.

Authors:  T Tuschl; P A Sharp; D P Bartel
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

4.  Optimization and optimality of a short ribozyme ligase that joins non-Watson-Crick base pairings.

Authors:  M P Robertson; J R Hesselberth; A D Ellington
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

5.  The three-dimensional architecture of the class I ligase ribozyme.

Authors:  Nicholas H Bergman; Nelson C Lau; Valerie Lehnert; Eric Westhof; David P Bartel
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

6.  Combinatorial minimization and secondary structure determination of a nucleotide synthase ribozyme.

Authors:  Kelly E Chapple; David P Bartel; Peter J Unrau
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

7.  De novo synthesis and development of an RNA enzyme.

Authors:  Yoshiya Ikawa; Kentaro Tsuda; Shigeyoshi Matsumura; Tan Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

Review 8.  Closing the circle: replicating RNA with RNA.

Authors:  Leslie K L Cheng; Peter J Unrau
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-16       Impact factor: 10.005

9.  RNA-directed construction of structurally complex and active ligase ribozymes through recombination.

Authors:  Eric J Hayden; Craig A Riley; Aaron S Burton; Niles Lehman
Journal:  RNA       Date:  2005-09-21       Impact factor: 4.942

10.  Direct selection of trans-acting ligase ribozymes by in vitro compartmentalization.

Authors:  Matthew Levy; Karl E Griswold; Andrew D Ellington
Journal:  RNA       Date:  2005-08-30       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.